Various genome-wide association studies (GWASs) identified new head and neck cancer (HNC) susceptibility loci, although the evidence has not been systematically summarized. We performed a systematic review and meta-analyses of the GWASs to identify the most commonly reported genetic loci associated with a risk of HNC.
Data Sources
We searched the PubMed, ISI Web of Science, SCOPUS, and GWAS databases to retrieve eligible studies, in English or Italian, published until June 1, 2017.
Review Methods
Only GWASs reporting data on the association between single-nucleotide polymorphisms (SNPs) and HNC were included. The quality of included studies was evaluated using the Q-Genie tool. Random-effect meta-analyses were performed considering only SNPs with at least 1 significant result from the included articles, and pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
Results
Seven studies of case-control design were included in the review. Five studies on nasopharyngeal cancer (NPC) in Chinese, reporting on 27 different SNPs, were included in meta-analyses. Results show that 6 SNPs (rs2076483, rs2975042, rs9258122, rs29232, and rs9510787) had an increased pooled estimates for A risk alleles (OR [95% CI]: 1.55 [1.36-1.77], 1.90 [1.69-2.14], 1.47 [1.31-1.65], 1.52 [1.32-1.76], and 1.22 [1.13-1.31], respectively) while G risk allele of rs3129055 reported an OR of 1.49 (95% CI, 1.33-1.67).
Conclusion
Our systematic review identified 5 SNPs located on chromosome 6 (rs2076483, rs2975042, rs3129055, rs9258122, and rs29232) and 1 (rs9510787) on chromosome 13 as significantly associated with an increased risk of NPC in Chinese.
MarurSForastiereAA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489-501.
2.
FerlayJSoerjomataramIDikshitRet al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.
3.
BocciaSCadoniGSayed-TabatabaeiFAet al. CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol. 2007;134:93-100.
4.
LeemansCRBraakhuisBJMBrakenhoffRH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9-22.
5.
WuM-YHuangS-JYangFet al. Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology. Oncotarget. 2017;8:52708-52723.
6.
WilkinsOMTitusAJGuiJet al. Genome-scale identification of microRNA-related SNPs associated with risk of head and neck squamous cell carcinoma. Carcinogenesis. 2017;38:986-993.
7.
LiuHGaoFDahlstromKRet al. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck. Tumor Biol. 2016;37:8057-8066.
8.
CadoniGBocciaSPetrelliLet al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism. Acta Otorhinolaryngol Ital. 2012;32:1-11.
9.
ChoE-YHildesheimAChenC-Jet al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev. 2003;12:1100-1104.
10.
TseK-PSuW-HChangK-Pet al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet. 2009;85:194-203.
11.
SimonsMJWeeGBDayNEMorrisPJShanmugaratnamKDe-ThéGB. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer. 1974;13:122-134.
12.
SudAKinnersleyBHoulstonRS. Genome-wide association studies of cancer: current insights and future perspectives. Nat Rev Cancer. 2017;17:692-704.
13.
Raab-TraubN. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002;12:431-441.
WangWYSBarrattBJClaytonDGToddJA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet. 2005;6:109-118.
16.
ManolioTA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166-176.
17.
JohnsonADO’DonnellCJ. An open access database of genome-wide association results. BMC Med Genet. 2009;10:6.
18.
IoannidisJPACastaldiPEvangelouE. A compendium of genome-wide associations for cancer: critical synopsis and reappraisal. J Natl Cancer Inst. 2010;102:846-858.
19.
EastonDFEelesRA. Genome-wide association studies in cancer. Hum Mol Genet. 2008;17(R2):R109-R115.
20.
GWAS Catalog. The NHGRI-EBI Catalog of published genome-wide association studies. https://www.ebi.ac.uk/gwas/. Accessed September 12, 2017.
21.
StadlerZKThomPRobsonMEet al. Genome-wide association studies of cancer. J Clin Oncol. 2010;28:4255-4267.
22.
RiazNMorrisLGLeeWChanTA. Unraveling the molecular genetics of head and neck cancer through genome-wide approaches. Genes Dis. 2014;1:75-86.
23.
LittleJHigginsJBrayMet al. The HuGENetTM HuGE Review Handbook, Version 1.0 Writing Group: On Behalf of the HuGE Net Systematic Review and Meta-Analysis Working Group. Ottawa, Canada: HuGENet Canada Coordinating Centre; 2006.
24.
SohaniZNMeyreDde SouzaRJet al. Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool. BMC Genet. 2015;16:50.
25.
SohaniZNSarmaSAlyassAet al. Empirical evaluation of the Q-Genie tool: a protocol for assessment of effectiveness. BMJ Open. 2016;6:e010403.
26.
ShamPCPurcellSM. Statistical power and significance testing in large-scale genetic studies. Nat Rev Genet. 2014;15:335-346.
27.
BushWSMooreJH. Genome-wide association studies. PLoS Comput Biol. 2012;8(12):e1002822.
28.
PanagiotouOAIoannidisJPAHirschhornJNet al. What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol. 2012;41:273-286.
29.
DerSimonianRLairdN. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
30.
DeeksJJ. Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001;323:157-162.
31.
HigginsJPTThompsonSGDeeksJJAltmanDG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
32.
BeiJ-XLiYJiaW-Het al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet. 2010;42:599-603.
33.
ChinYMMushirodaTTakahashiAet al. HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese. Int J Cancer. 2015;136:678-687.
34.
NgCCYewPYPuahSMet al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet. 2009;54:392-397.
35.
TangMLautenbergerJAGaoXet al. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet. 2012;8(11):e1003103.
36.
TseKPSuWHChangKPet al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet. 2009;85:194-203.
37.
WeiQYuDLiuMet al. Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population. Nat Genet. 2014;46:1110-1114.
38.
LesseurCDiergaardeBOlshanAFet al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48:1544-1550.
39.
LiXFasanoRWangEYaoK-TMarincolaFM. HLA associations with nasopharyngeal carcinoma. Curr Mol Med. 2009;9:751-765.
40.
TangMZengYPoissonAet al. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a southern Chinese population. Genes Immun. 2010;11:334-342.
41.
LuSDayNEDegosLet al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions. Nature. 1990;346:470-471.
42.
CaoS-MSimonsMJQianC-N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30:114-119.
43.
ZhangL-FLiY-HXieS-Het al. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis. Chin J Cancer. 2015;34:350-357.
44.
HoCS. Beating “Guangdong cancer”: a review and update on nasopharyngeal cancer. Hong Kong Med J. 2017;23:497-502.
45.
MenicagliRBollaGMenicagliLEsseiridouA. Industrial pollutants and nasopharyngeal cancer: an open question. Gulf J Oncolog. 2017;1:70-74.
46.
YuMCYuanJ-M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-429.
47.
PatelVJChenN-WRestoVA. Racial and ethnic disparities in nasopharyngeal cancer survival in the United States. Otolaryngol Head Neck Surg. 2017;156:122-131.
48.
OuS-HZellJAZiogasAAnton-CulverH. Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007;18:29-35.
49.
BhattacharyyaN. The impact of race on survival in nasopharyngeal carcinoma: a matched analysis. Am J Otolaryngol. 2004;25:94-97.
50.
SunL-MLiCIHuangE-YVaughanTL. Survival differences by race in nasopharyngeal carcinoma. Am J Epidemiol. 2006;165:271-278.
51.
NadeauJHTopolEJ. The genetics of health. Nat Genet. 2006;38:1095-1098.
52.
HarperARNayeeSTopolEJ. Protective alleles and modifier variants in human health and disease. Nat Rev Genet. 2015;16:689-701.
SuW-HYao ShugartYChangK-PTsangN-MTseK-PChangY-S. How genome-wide SNP-SNP interactions relate to nasopharyngeal carcinoma susceptibility. PLoS One. 2013;8:e83034.
55.
YuKJGaoXChenC-Jet al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol. 2009;70:910-914.
56.
HuSPDayNELiDRet al. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer. 2005;92:967-970.
57.
HildesheimAAppleRJChenC-Jet al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst. 2002;94:1780-1789.
58.
GeraghtyDEWeiXHOrrHTKollerBH. Human leukocyte antigen F (HLA-F): an expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J Exp Med. 1990;171:1-18.
59.
HassenENahlaGBouaouinaNChouchaneL. The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk. Mol Biol Rep. 2010;37:119-126.
60.
HildesheimAWangC-P. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011. Semin Cancer Biol. 2012;22:107-116.
61.
PurcellAWElliottT. Molecular machinations of the MHC-I peptide loading complex. Curr Opin Immunol. 2008;20:75-81.
62.
SkibolaCFBracciPMHalperinEet al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet. 2009;41:873-875.
63.
LiD-JBeiJ-XMaiS-Jet al. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma. J Med Virol. 2009;81:1253-1260.
64.
LeeNGeraghtyDE. HLA-F Surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol Ref. 2003;171:5264-5271.
65.
SenguptaSden BoonJAChenI-Het al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 2006;66:7999-8006.
66.
WatanabeMMaemuraKOkiKShiraishiNShibayamaYKatsuK. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. Histol Histopathol. 2006;21:1135-1141.
67.
TakeharaAHosokawaMEguchiHet al. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor subunit. Cancer Res. 2007;67:9704-9712.
68.
MatuszekMJesipowiczMKleinrokZ. GABA content and GAD activity in gastric cancer. Med Sci Monit. 2001;7:377-381.
69.
OpolskiAMazurkiewiczMWietrzykJKleinrokZRadzikowskiC. The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J Exp Clin Cancer Res. 2000;19:383-390.
70.
KleinrokZMatuszekMJesipowiczJMatuszekBOpolskiARadzikowskiC. GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J Physiol Pharmacol. 1998;49:303-310.
71.
HuSTamadaKNiJVincenzCChenL. Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily. Genomics. 1999;62:103-107.
72.
EbyMTJasminAKumarASharmaKChaudharyPM. TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J Biol Chem. 2000;275:15336-15342.
73.
ChanASToKFLoKWet al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res. 2000;60:5365-5370.
74.
StewartPLNemerowGR. Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol. 2007;15:500-507.
75.
DasSBhowmikABhattacharjeeAet al. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions. Tumor Biol. 2015;36:7569-7579.
76.
LiangCMarsitCJHousemanEAet al. Gene-environment interactions of novel variants associated with head and neck cancer. Head Neck. 2012;34:1111-1118.
77.
HuangC-CHsiaoJ-RLeeW-Tet al. Investigating the association between alcohol and risk of head and neck cancer in Taiwan. Sci Rep. 2017;7:9701.
78.
LungMLCheungAKLKoJMYLungHLChengYDaiW. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma. Chin J Cancer. 2014;33:556-568.
79.
BurgosJS. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol. 2005;22:113-122.
80.
KamranSCRiazNLeeN. Nasopharyngeal carcinoma. Surg Oncol Clin North Am. 2015;24:547-561.
81.
TsangCMTsaoSW. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Virol Sin. 2015;30:107-121.
82.
KraftPZegginiEIoannidisJ. Replication in genome-wide association studies. Stat Sci. 2010;24:561-573.
83.
ZimmernRLKhouryMJ. The impact of genomics on public health practice: the case for change. Public Health Genomics. 2012;15:118-124.
84.
BurtonHJacksonCAbubakarI. The impact of genomics on public health practice. Br Med Bull. 2014;112:37-46.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
